HER2 Positive Gastric Carcinomas and Their Clinico-Pathological Characteristics
Journal
Open Access Macedonian Journal of Medical Sciences
Date Issued
2018-07-20
Author(s)
Gjoshev, Stojan
Hadzi-Manchev, Dragan
Volcevski, Goce
Fildishevski, Igor
DOI
10.3889/oamjms.2018.280
Abstract
HER2 protein expression in gastric carcinoma, in correlation with existing, acknowledged prognostic factors which include the parameters that determine the TNM stage of the disease, could become the basis for ongoing research in the field of molecular targeted and personalised therapy.
